Cardiovascular Disease Mechanisms in HIV Infected and Uninfected Veterans
Cardiovascular Disease Mechanisms in HIV Infected and Uninfected Veterans
批准号:
8114595
负责人:
MATTHEW S FREIBERG
金额:
$9.76万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-25 至 2013-06-30
关键词:
AbbreviationsAbdomenAcquired Immunodeficiency SyndromeAdherenceAdipose tissueAdultAdverse eventAftercareAgeAgingAlberta provinceAlcohol abuseAlcohol consumptionAlcohol or Other Drugs useAlcoholsAreaAtherosclerosisBiological MarkersBloodBlood BanksBlood PressureBody CompositionBody mass indexC-reactive proteinCD4 Lymphocyte CountCalciumCardiacCardiologyCardiovascular DiseasesCardiovascular systemCaringCentral obesityCholesterolClinicalClinical DataClinical TrialsCoagulation ProcessCocaineCohort StudiesComorbidityComputerized Medical RecordCongestive Heart FailureCoronary arteryCoronary heart diseaseDataData CollectionDevelopmentDiseaseDisease OutcomeDyslipidemiasEchocardiographyEducationElectrocardiogramElectron BeamElectron Beam TomographyEnrollmentEnsureEpidemiologyEtiologyEventFibrinolysisFunctional disorderFutureGeneticHIVHIV Envelope Protein gp120HealthHealth SurveysHealth behaviorHepatitis CHepatitis C virusHigh Density LipoproteinsHigh PrevalenceIn VitroIndividualInfectionInflammationInflammatoryInflammatory ResponseInsulin ResistanceInternational Classification of DiseasesJusticeKidney DiseasesLaboratoriesLeftLeft Ventricular Ejection FractionLeft Ventricular HypertrophyLeft ventricular structureLipidsLipoproteinsLow-Density LipoproteinsLung diseasesMeasuresMedicalMedical centerMentorsMetabolicMinorityModelingMyocardial InfarctionMyocardiumNational Heart, Lung, and Blood InstituteObservational StudyOpportunistic InfectionsOutcomeParticipantPatientsPericardial body locationPharmaceutical PreparationsPharmacy facilityPhysical FunctionPlant LeavesPlatelet aggregationPopulationPopulation ControlPositioning AttributePrevalencePreventiveProspective StudiesProtease InhibitorProteinsProtocols documentationPulmonary HypertensionRaceRadiology SpecialtyRegimenResearch PersonnelRetroviridaeReverse Transcriptase InhibitorsRiskRisk FactorsRoleSamplingSiteSmokeSmooth Muscle MyocytesStructureTestingThromboplastinThrombosisTissuesToxic effectVasospasmVentricularVeteransViral Load resultVirusVirus DiseasesVisceralWomen&aposs HealthWorkX-Ray Computed Tomographyabstractingadjudicatealcohol use disorderantiretroviral therapyaortic valvecardiovascular disorder riskcocaine usecofactorcohortcytokinedesigndrinkingexperiencefasting glucosefitnessfollow-upimprovedinflammatory markermedication compliancemortalityprogramsprospectiveskillssubcutaneoussymposiumtherapy adherencetreatment planning
中文摘要
摘要
在使用人群控制的研究中,HIV感染与心血管疾病风险增加有关。
疾病(CVD)。然而,这种风险可能部分由艾滋病毒或其治疗以外的因素解释
包括吸烟、酗酒、可卡因使用、丙型肝炎感染和肾脏疾病的发病率较高。同样
重要的是,HIV感染者中CVD的主要机制可能与未感染者不同,
脂质异常突然发生-在开始联合抗逆转录病毒治疗(CART)后,
HIV和HCV的炎症作用、酒精的毒性作用和可卡因引起的血管痉挛。退伍军人
老龄队列研究(VACS)是一项正在进行的、多中心、前瞻性研究,共有3227名退伍军人感染HIV
和3240名年龄/种族/地点匹配的HIV未感染对照。与国际知名专家合作,
CVD,我们建议用裁定的CVD终点补充该队列中可用的丰富临床数据,
以及CVD风险的生物标志物和测量,包括:血脂异常、胰岛素抵抗、
炎症、心脏结构和功能异常、身体成分变化、亚临床
动脉粥样硬化、心脏适应性以及与血栓形成和纤维蛋白溶解相关的改变。与这些
丰富的数据,我们将处于独特的地位,以确定是否:1)艾滋病毒感染是一个独立的风险
CVD终点的因素以及HCV、物质使用和CART是否改变了HIV
和CVD终点,2)在HIV感染者中,CVD风险的生物标志物和指标增加
和CART不依从,3)HCV感染者中CVD风险的生物标志物和指标增加
感染和物质使用。重要的是,我们将调整CART依从性和竞争风险,因为
艾滋病毒感染者的死亡率高得多。大的,特征鲜明的,老的,
主要是少数患者样本,具有良好的纵向随访和HCV的高患病率,
物质使用,全面的药房数据,并建立全面的电子医疗访问
记录是此应用程序的重要优势。强大的CVD专业知识,
VACS团队的指导技能,以及一个多PI计划,包括一个有前途的新调查员,确保
这一建议将有效地促进我们对艾滋病毒感染者心血管疾病结局和机制的理解,
感染和未感染的人。
英文摘要
ABSTRACT
In studies using population controls, HIV infection has been associated with increased risk of cardiovascular
disease (CVD). However, this risk may be partially explained by factors other than HIV or its treatment
including higher rates of smoking, alcohol abuse, cocaine use, hepatitis C infection and renal disease. Equally
important, major mechanisms of CVD among those with HIV likely differ from those without infection because
lipid abnormalities occur abruptly--after initiation of combination antiretroviral therapy (CART), and because of
inflammatory effects of HIV and HCV, toxic effects of alcohol and vasospasm due to cocaine. The Veterans
Aging Cohort Study (VACS) is an ongoing, multicenter, prospective study of 3227 veterans with HIV infection
and 3240 age/race/site matched HIV uninfected controls. Teamed with internationally recogized experts in
CVD, we propose to supplement the rich clinical data available in this cohort with adjudicated CVD endpoints,
and biomarkers and measures of CVD risk including: dyslipidemia, insulin resistance , markers of
inflammation, cardiac structural and functional abnormalities, body composition changes, subclinical
atherosclerosis, cardiac fitness, and alterations associated with thrombogenesis and fibrinolysis. With these
enriched data we will be uniquely positioned to determine whether: 1) HIV infection is an independent risk
factor for CVD endpoints and whether HCV, substance use and CART modify the association between HIV
and CVD endpoints, 2) biomarkers and measures of CVD risk are increased among those with HIV infection
and CART nonadherence, and 3) biomarkers and measures of CVD risk are increased among those with HCV
infection and substance use. Importantly, we will adjust for both CART adherence and competing risk, since
HIV infected individuals have a substantially higher mortality rate. The large, well characterized, older,
predominantly minority patient sample with excellent longitudinal follow up and high prevalence of HCV and
substance use, comprehensive pharmacy data, and established access to comprehensive electronic medical
records are important leveraged strengths of this application. The strong CVD expertise, established analytic
and mentoring skills of the VACS team, and a multi-PI plan incorporating a promising new investigator ensure
that this proposal will effectively advance our understanding of CVD outcomes and mechanisms among HIV
infected and uninfected individuals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Microbiome, metabolites, and alcohol in HIV to reduce CVD RCT (META HIV CVD RCT)
-
批准号:10685513
-
项目类别:
-
资助金额:$85.26万
-
财政年份:2021
-
负责人:MATTHEW S FREIBERG
-
依托单位:
Administrative, Education, and Analytic Support Core
-
批准号:10304047
-
项目类别:
-
资助金额:$17.77万
-
财政年份:2021
-
负责人:MATTHEW S FREIBERG
-
依托单位:
Microbiome, metabolites, and alcohol in HIV to reduce CVD RCT (META HIV CVD RCT)
-
批准号:10685704
-
项目类别:
-
资助金额:$21.58万
-
财政年份:2021
-
负责人:MATTHEW S FREIBERG
-
依托单位:
Microbiome, metabolites, and alcohol in HIV to reduce CVD RCT (META HIV CVD RCT)
-
批准号:10304049
-
项目类别:
-
资助金额:$58.7万
-
财政年份:2021
-
负责人:MATTHEW S FREIBERG
-
依托单位:
Administrative, Education, and Analytic Support Core
-
批准号:10685508
-
项目类别:
-
资助金额:$14.1万
-
财政年份:2021
-
负责人:MATTHEW S FREIBERG
-
依托单位:
Vanderbilt SCHolars in HIV and Heart, Lung, Blood, and Sleep ReSearch (V-SCHoLARS, K12)
-
批准号:10429901
-
项目类别:
-
资助金额:$34.64万
-
财政年份:2018
-
负责人:MATTHEW S FREIBERG
-
依托单位:
Vanderbilt SCHolars in HIV and Heart, Lung, Blood, and Sleep ReSearch (V-SCHoLARS, K12)
-
批准号:10202711
-
项目类别:
-
资助金额:$40.06万
-
财政年份:2018
-
负责人:MATTHEW S FREIBERG
-
依托单位:
Vanderbilt SCHolars in HIV and Heart, Lung, Blood, and Sleep ReSearch (V-SCHoLARS, K12)
-
批准号:9761561
-
项目类别:
-
资助金额:$40.03万
-
财政年份:2018
-
负责人:MATTHEW S FREIBERG
-
依托单位:
ST. PETER HIV-Alcohol, Protein Biomarkers and Cardiovascular Disease Risk
-
批准号:9349871
-
项目类别:
-
资助金额:$19.96万
-
财政年份:2017
-
负责人:MATTHEW S FREIBERG
-
依托单位:
ST. PETER HIV-Alcohol, Protein Biomarkers and Cardiovascular Disease Risk
-
批准号:9770731
-
项目类别:
-
资助金额:$19.96万
-
财政年份:2017
-
负责人:MATTHEW S FREIBERG
-
依托单位:
Immune function and the risk of cvd among HIV infected and uninfected veterans
-
批准号:9268918
-
项目类别:
-
资助金额:$28.92万
-
财政年份:2014
-
负责人:MATTHEW S FREIBERG
-
依托单位:
Immune function and the risk of cvd among HIV infected and uninfected veterans
-
批准号:8790187
-
项目类别:
-
资助金额:$75.43万
-
财政年份:2014
-
负责人:MATTHEW S FREIBERG
-
依托单位:
HIV, Depression, and Cardiovascular Risk
-
批准号:8847467
-
项目类别:
-
资助金额:$74.12万
-
财政年份:2014
-
负责人:MATTHEW S FREIBERG
-
依托单位:
HIV, Depression, and Cardiovascular Risk
-
批准号:8929009
-
项目类别:
-
资助金额:$73.07万
-
财政年份:2014
-
负责人:MATTHEW S FREIBERG
-
依托单位:
Zinc for HIV Disease among Alcohol Users -An RCT in the Russia ARCH Cohort
-
批准号:9126388
-
项目类别:
-
资助金额:$64.9万
-
财政年份:2012
-
负责人:MATTHEW S FREIBERG
-
依托单位:
Zinc for HIV Disease among Alcohol Users -An RCT in the Russia ARCH Cohort
-
批准号:9346822
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2012
-
负责人:MATTHEW S FREIBERG
-
依托单位:
Zinc for HIV Disease among Alcohol Users -An RCT in the Russia ARCH Cohort
-
批准号:8448518
-
项目类别:
-
资助金额:$63.47万
-
财政年份:2012
-
负责人:MATTHEW S FREIBERG
-
依托单位:
Translational Research on Alcohol, Immunodeficiency, and Aging In COMpAAAS
-
批准号:8719886
-
项目类别:
-
资助金额:$42.59万
-
财政年份:2012
-
负责人:MATTHEW S FREIBERG
-
依托单位:
Zinc for HIV Disease among Alcohol Users -An RCT in the Russia ARCH Cohort
-
批准号:8549930
-
项目类别:
-
资助金额:$54.52万
-
财政年份:2012
-
负责人:MATTHEW S FREIBERG
-
依托单位:
Zinc for HIV Disease among Alcohol Users -An RCT in the Russia ARCH Cohort
-
批准号:8716620
-
项目类别:
-
资助金额:$55.98万
-
财政年份:2012
-
负责人:MATTHEW S FREIBERG
-
依托单位:
海外基金